Efficacy of plasmin–treated intravenous gamma–globulin for therapy of kawasaki syndrome

Pediatric Infectious Disease Journal

Volumn 12, Issue 6, 1993, Pages 509-512

  Hsu, Ching Hsiang ^a   Chen, Ming Ren ^a   Hwang, Fu Yuang ^a   Kao, Hsin An ^a   Hung, Han Yang ^a   Hsu, Chyong Hsin ^a  

^a Department of Nursing Mackay Memorial Hospital   (China)

Author keywords

Coronary artery aneurysms; IgG FC fragment; Kawasaki syndrome; Plasmin treated intravenous gamma globulin

Indexed keywords

ACETYLSALICYLIC ACID; DIPHENHYDRAMINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN FC FRAGMENT; PLASMIN;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; DRUG EFFICACY; FEMALE; FEVER; HEADACHE; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; SHIVERING; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ASPIRIN; CHI-SQUARE DISTRIBUTION; COMPARATIVE STUDY; CORONARY VESSEL ANOMALIES; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; FEMALE; HUMAN; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PLASMIN; PREVALENCE; TREATMENT OUTCOME;

EID: 0027266807     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/00006454-199306000-00010     Document Type: Article

References (18)

1. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yangawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974;54:271-6.
2. Chung KJ, for the U. S. Multicenter Kawasaki Disease Study Group. Incidence and prognosis of giant coronary artery aneurysms in Kawasaki disease. Circulation 1989;80(Suppl II):282.
3. Nakamura Y, Fujita Y, Nagai M, et al. Cardiac sequelae of Kawasaki disease in Japan: statistical analysis. Pediatrics 1991;88:1144-7.
4. Furusho, Kamiya T, Nakano H, et al. High-dose intravenous gamma-globulin for Kawasaki disease. Lancet 1984;2:1055-8.
5. Rowley AH, Shulman ST. What is the status of intravenous gamma-globulin for Kawasaki syndrome in the United States and Canada ? Pediatr Infect Dis J 1988;7:663-5.
6. American Academy of Pediatrics Committee of Infectious Disease. Intravenous gammaglobulin use in children with Kawasaki disease. Pediatrics 1988;82:122.
7. Newburger JW, Takahashi J, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gammaglobulin. N Engl J Med 1986;315:341-7.
8. Newburger JW, Takahashi M, Beiser AS, et al. A single infusion of intravenous gammaglobulin compared to four daily doses in the treatment of acute Kawasaki syndrome. N Engl J Med 1991;324:1633-9.
9. Greenbaum BH. Differences in immunoglobulin preparations for intravenous use: a comparison of six products. Am J Pediatr Hematol Oncol 1990;12:490-6.
10. Sultan Y, Kazatchkine M, Maisonneuve P, Nydegger VE. An- tiidiotypic suppression of auto-antibodies to Factor VIII (anti hemophilic factor) by high dose intravenous gammaglobulin. Lancet 1984;2:765-8.
11. Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 1991;33(6):805-10.
12. The Japan Kawasaki Disease Research Committee. Diagnostic guideline of Kawasaki disease. 4th rev ed. Tokyo: Japan Red Cross Medical Center, 1984.
13. Basta M, Kirshbom P, Frank MM, Fries LF. Mechanism of therapeutic effect of high-dose intravenous immunoglobulin: attenuation of acute, complement-dependent immune damage in a guinea pig model. J Clin Invest 1989;84:1974-81.
14. Leung DYM, Kurt-Jones E, Newburger JW, Cotran RS, Burns JC, Fober JS. Endothelial cell activation and high interleukin 1 secretion in the pathogenesis of acute Kawasaki disease. Lancet 1989;2:1298-1302.
15. Savage COS, Tizard J, Jayne DRW, Lockwood CM, Dilzon MJ. Antineutrophil cytoplasm antibodies in Kawasaki disease. Arch Dis Child 1989;64:360-3.
16. Iwata M, Shimozato R, Tokiwa H, Tsubura E. Antipyretic activity of human immunoglobulin preparations for intravenous use in an experimental model of fever in rabbits. In: Morell A, Nydegger VE, eds. Clinical use of intravenous immunoglobulins. New York: Academic Press, 1986:327-37.
17. Durandy A, Fischer A, Criscelli C. Dysfunction of pokeweed mitogen stimulated T and B lymphocytes responses included by gammaglobulin therapy. J Clin Invest 1981;67:867-77.
18. Knudsen PJ, Dinarello CA, Strom TB. prostaglandins post transcriptionally inhibit monocyte expression of interleukin 1 activity by increasing intra cellular cyclic adenosine monophosphate. J Immunol 1986;137:3189-94.